Policy: Interested Parties Meeting

On Thursday, December 5, 2024, the WMC will hold a Policy: Interested Parties meeting beginning at 10 am. The meeting will be held virtually via Teams. Register to attend this meeting here: WMC Policy: Interested Parties. The purpose of this meeting is to allow anyone to comment on and suggest changes to the WMC’s policies, guidance documents, procedures, and interpretive statements. The agenda, as well as the draft documents to be discussed, can be found in the meeting packet on our Policy Meetings page.

Understanding the  Practitioner Support Program

The WMC has implemented a Practitioner Support Program (PSP) to aid licensees in improving their practice without the need for discipline. The PSP provides support and educational resources for common complaints including communication, systems-based issues and medical record keeping. Join us for a Coffee with the Commission where we will explain how the PSP works, what the licensee can expect if they receive a PSP letter and the value of engaging with the WMC through the PSP. View the Recording

From The FAQ Page

Q: How long does it take to resolve my complaint?

A: The time will vary depending on the nature of the complaint, the complexity of the case and the cooperation of all parties involved. Patience is needed when dealing with the many legal and health care investigations. Cases may take as little as a few weeks or, in some cases, as long as two years. Read More on the FAQ Page

Resources and Guidance for Practitioners and Pain Patients Following a Practitioner Restriction

The recent restriction of Dr. Sjardo Steneker may limit or curtail patients’ access to care. As a result, the WMC anticipates a potential increase in patients seeking medications, including those used to treat chronic pain, and new healthcare providers. Continue Reading

For Chronic Pain Patients

There are no absolute limits on Morphine Equivalent Dose (MED) for pain management. Your prescriber, whether an MD or physician assistant, has the flexibility to prescribe above the suggested MED guidelines if they believe it is necessary for your treatment. If they do prescribe above these guidelines, they must document the reasons in your medical record to ensure the decision is well-supported and meets your specific needs.

If an MD or PA prescribes a daily dosage of 120 mg MED or more, they are required to consult with a pain management specialist unless exempted by certain provisions. This consultation may involve an office visit, a remote or in-person discussion between the specialist and the MD or PA, an audio-visual evaluation with the patient present, or other approved chronic pain evaluation services. Each consultation must be documented in the patient's medical record by the MD or PA.

Additionally, there are no tapering requirements in rule for MDs or PAs, allowing your provider to make individualized treatment decisions based on your specific circumstances.